Based on positive clinical trial results, Seattle Genetics intends to file a marketing application for the #breastcancer drug, called tucatinib, with the FDA early next year. https://t.co/o6Qm8iOPyp
A new form of the genome-editing tool CRISPR-Cas9 appears to significantly expand the range of diseases that could be treated with the technology. https://t.co/cOvJBtWwGU
Opinion: Although new delivery methods will help telehealth expand, they are sometimes handcuffed by varied and conflicting state and federal rules. https://t.co/ZlWSzqRc6K
House Democratsโ signature legislation to lower the cost of prescription drugs will be named for the late Rep. Elijah Cummings. https://t.co/Sjo0G6wq6t